** Shares of Indian balm-maker Amrutanjan Health Care Ltd
AJAN.NS fall as much as 9.29% to 636.70 rupees - lowest since
May 10, 2021
** Co sees steepest intraday loss since Aug. 16, 2022
** The anti-headache roll-on maker reports a near 48% plunge
in Q3 PAT to 107.1 mln rupees ($1.29 mln)
** Rev from ops falls 11.8% to 976.5 mln rupees
** Co says it received anonymous whistleblower allegations
concerning senior management
** Allegations pertain to "lapses, including undue
enrichment through marketing, advertising and procurement
activities, ethical concerns and conflict of interest" - AJAN
** Co says it has initiated forensic investigation by
Deloitte Touche Tohmatsu India LLP
** Shares trading below 50-day and 100-day moving averages
** Stock slid ~24% in 2022
($1 = 82.8650 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com; +91 9830427878))